Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | FORM S-1 | d254016ds1.htm | S-1 | 2369768 |
2 | AMENDED AND RESTATED CERTIFICATE OF INCORPORATION | d254016dex31.htm | EX-3.1 | 80716 |
3 | BYLAWS | d254016dex33.htm | EX-3.3 | 53679 |
4 | REGISTRATION RIGHTS AGREEMENT | d254016dex42.htm | EX-4.2 | 52232 |
5 | AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT | d254016dex43.htm | EX-4.3 | 68605 |
6 | AMENDMENT TO AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT | d254016dex44.htm | EX-4.4 | 11686 |
7 | AMENDED AND RESTATED STOCKHOLDERS' AGREEMENT | d254016dex45.htm | EX-4.5 | 68006 |
8 | SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT | d254016dex46.htm | EX-4.6 | 162167 |
9 | AMENDMENT TO SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT | d254016dex47.htm | EX-4.7 | 9652 |
10 | FORM OF SHORT FORM WARRANT | d254016dex48.htm | EX-4.8 | 22087 |
11 | FORM OF SHORT FORM CASHLESS EXERCISE WARRANT | d254016dex49.htm | EX-4.9 | 26119 |
12 | FORM OF MEDIUM FORM WARRANT | d254016dex410.htm | EX-4.10 | 54759 |
13 | FORM OF LONG FORM WARRANT | d254016dex411.htm | EX-4.11 | 51176 |
14 | CONVERTIBLE PROMISSORY NOTE | d254016dex412.htm | EX-4.12 | 17818 |
15 | CONVERTIBLE PROMISSORY NOTE | d254016dex413.htm | EX-4.13 | 15900 |
16 | 2008 STOCK OPTION PLAN | d254016dex101.htm | EX-10.1 | 58531 |
17 | FORM OF NOTICE OF STOCK OPTION GRANT | d254016dex102.htm | EX-10.2 | 12362 |
18 | FORM OF STOCK OPTION GRANT AGREEMENT | d254016dex103.htm | EX-10.3 | 27298 |
19 | FORM OF EXERCISE NOTICE AND RESTRICTED STOCK PURCHASE AGREEMENT | d254016dex104.htm | EX-10.4 | 41157 |
20 | 2011 EQUITY COMPENSATION PLAN | d254016dex105.htm | EX-10.5 | 89009 |
21 | FORM OF STOCK OPTION GRANT AGREEMENT | d254016dex106.htm | EX-10.6 | 90484 |
22 | FORM OF INDEMNIFICATION AGREEMENT | d254016dex107.htm | EX-10.7 | 76414 |
23 | CONSULTING AGREEMENT BETWEEN CANCER GENETICS, INC. AND TSG, LLC | d254016dex108.htm | EX-10.8 | 110396 |
24 | MEDICAL DIRECTOR AGREEMENT | d254016dex109.htm | EX-10.9 | 27690 |
25 | EMPLOYMENT AGREEMENT BETWEEN CANCER GENETICS, INC. AND LOUIS J. MAIONE | d254016dex1010.htm | EX-10.10 | 69752 |
26 | CONSULTING AGREEMENT BETWEEN CANCER GENETICS, INC. AND LOUIS MALONE | d254016dex1011.htm | EX-10.11 | 30839 |
27 | TERMINATION AGREEMENT | d254016dex1012.htm | EX-10.12 | 31969 |
28 | CONSULTING AGREEMENT BETWEEN CANCER GENETICS, INC. AND EDMUND CANNON | d254016dex1013.htm | EX-10.13 | 17018 |
29 | CONSULTING AGREEMENT BETWEEN CANCER GENETICS, INC. AND ANDREW PECORA | d254016dex1014.htm | EX-10.14 | 32088 |
30 | CONSULTING AGREEMENT BETWEEN CANCER GENETICS, INC. AND R.S.K. CHAGANTI | d254016dex1015.htm | EX-10.15 | 51424 |
31 | CONSULTING AGEEMENT BETWEEN CANCER GENETICS, INC. AND TSG, LLC | d254016dex1016.htm | EX-10.16 | 53483 |
32 | CREDIT AGREEMENT BETWEEN CANCER GENETICS, INC. AND WELLS FARGO BANK N.A. | d254016dex1021.htm | EX-10.21 | 56300 |
33 | SECURITY AGREEMENT BETWEEN CANCER GENETICS, INC AND WELLS FARGO BANK N.A. | d254016dex1022.htm | EX-10.22 | 37999 |
34 | FIRST ADDENDUM TO CREDIT AGREEMENT | d254016dex1023.htm | EX-10.23 | 26687 |
35 | SECOND ADDENDUM TO CREDIT AGREEMENT | d254016dex1024.htm | EX-10.24 | 61793 |
36 | THIRD ADDENDUM TO CREDIT AGREEMENT | d254016dex1025.htm | EX-10.25 | 61755 |
37 | FOURTH ADDENDUM TO CREDIT AGREEMENT | d254016dex1026.htm | EX-10.26 | 64472 |
38 | FIFTH ADDENDUM TO CREDIT AGREEMENT | d254016dex1027.htm | EX-10.27 | 43679 |
39 | CREDIT AGREEMENT BETWEEN CANCER GENETICS, INC. AND DAM HOLDINGS, LLC | d254016dex1028.htm | EX-10.28 | 175554 |
40 | INTER-CREDITOR AGREEMENT | d254016dex1029.htm | EX-10.29 | 18218 |
41 | GENERAL BUSINESS SECURITY AGREEMENT | d254016dex1030.htm | EX-10.30 | 80845 |
42 | PROMISSORY NOTE ISSUED BY CANCER GENETICS, INC. | d254016dex1031.htm | EX-10.31 | 8967 |
43 | SIXTH CREDIT AGREEMENT | d254016dex1032.htm | EX-10.32 | 61804 |
44 | AFFILIATION AGREEMENT | d254016dex1035.htm | EX-10.35 | 77633 |
45 | SUBSIDIARIES OF CANCER GENETICS, INC | d254016dex211.htm | EX-21.1 | 704 |
46 | CONSENT OF MCGLADREY & PULLEN, LLP | d254016dex231.htm | EX-23.1 | 1739 |
47 | GRAPHIC | g254016cov_pg001.jpg | GRAPHIC | 7032 |
48 | GRAPHIC | g254016exh_pg01.jpg | GRAPHIC | 3015 |
49 | GRAPHIC | g254016exi_pg01.jpg | GRAPHIC | 2187 |
50 | GRAPHIC | g254016exj_pg004.jpg | GRAPHIC | 3342 |
51 | GRAPHIC | g254016exp_pg04.jpg | GRAPHIC | 3827 |
52 | GRAPHIC | g254016exs.jpg | GRAPHIC | 7691 |
53 | GRAPHIC | g254016ext_pg01.jpg | GRAPHIC | 8102 |
54 | GRAPHIC | g254016g06a66.jpg | GRAPHIC | 1674 |
55 | GRAPHIC | g254016g40r62.jpg | GRAPHIC | 121892 |
56 | GRAPHIC | g254016g46l08.jpg | GRAPHIC | 102415 |
57 | GRAPHIC | g254016g68r58.jpg | GRAPHIC | 124243 |
58 | GRAPHIC | g254016g90k64.jpg | GRAPHIC | 45020 |
59 | GRAPHIC | g254016g95s47.jpg | GRAPHIC | 120961 |
60 | GRAPHIC | g254016wellslogo.jpg | GRAPHIC | 3827 |
Complete submission text file | 0001193125-11-356362.txt | 5430489 |
IRS No.: 043462475 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-178836 | Film No.: 111289414